Waverton Investment Management Ltd Trims Position in Colgate-Palmolive (NYSE:CL)

Waverton Investment Management Ltd lowered its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 42.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,947 shares of the company's stock after selling 5,900 shares during the quarter. Waverton Investment Management Ltd's holdings in Colgate-Palmolive were worth $825,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at $25,000. Continuum Advisory LLC grew its stake in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at $53,000. Finally, Gradient Investments LLC grew its stake in shares of Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after buying an additional 400 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an "equal weight" rating in a research note on Monday, July 29th. StockNews.com raised Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Wednesday, November 6th. HSBC reissued a "hold" rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a report on Monday, October 28th. Finally, Hsbc Global Res downgraded Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a report on Friday, July 26th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Colgate-Palmolive Stock Performance

NYSE CL traded down $0.45 on Tuesday, hitting $91.51. 4,927,123 shares of the company's stock were exchanged, compared to its average volume of 4,377,176. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm's 50-day moving average price is $100.62 and its two-hundred day moving average price is $98.52. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30. The firm has a market cap of $74.76 billion, a price-to-earnings ratio of 26.36, a P/E/G ratio of 3.31 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.34% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.